LONDON — Two years after the large multinational PROTECTED TAVR trial failed to associate a cerebral embolic protection (CEP ... “there is little prospect of demonstrating a benefit in the primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback